Alterations in gene expression after gamma-hydroxybutyric acid intake-A pilot study

Area of Science:

• Pharmacology
• Molecular Biology
• Forensic Science

Background:

• Gamma-hydroxybutyric acid (GHB) is a CNS depressant with therapeutic uses and illicit applications.
• GHB's narrow detection window complicates identification of its ingestion.
• Identifying reliable biomarkers for GHB intake is crucial for forensic and clinical purposes.

Purpose of the Study:

• To investigate differential gene expression in response to GHB intake.
• To identify potential gene expression biomarkers for GHB detection.
• To establish a robust normalization strategy for quantitative PCR (qPCR) data in GHB-related studies.

Main Methods:

• Quantitative PCR (qPCR) was used to analyze gene expression of ALDH5A1, AKR7A2, EREG, and PEA15.
• Blood samples from GHB-treated patients (n=3) and a control group (n=49) were analyzed.
• An empirically derived normalization strategy and MIQE guidelines were applied.

Main Results:

• No significant alterations in the expression of targeted genes were confirmed to a forensically sufficient degree after GHB intake.
• Significant differences in EREG expression within the control group suggested a circadian rhythm influence.
• A novel, empirically derived normalization strategy for qPCR data was successfully implemented.

Conclusions:

• The pilot study did not identify sufficient gene expression biomarkers for GHB intake.
• Circadian rhythms may influence gene expression, impacting biomarker studies.
• Further research with larger sample sizes is needed to validate potential GHB biomarkers.